HUGO Publication Committee is a newly formed committee. It acts as the driving force for all HUGO publications, namely The HUGO Journal. The Committee directs and guides the publishing directions and editorial structure of all publication projects under the auspices of HUGO. It also helps promote all HUGO publications among their networks.

Committee Members

Prof Anthony Brookes (UK) Chairperson Professor Brookes is an internationally recognized leader in genomics and bioinformatics, having made significant contributions to method development, disease and population genetics, DNA variation analysis, and database systems for organizing genomics information. His publications include over 100 peer-reviewed articles and reviews. Most recently, he uncovered a major new aspect of DNA polymorphism comprising abundant copy-number differences for many short and long-range sections of the human genome. Professor Brookes has filed 6 patent applications on cloning, genotyping, and DNA analysis methods, and he has also founded the company DynaMetrix which markets genotyping products and solutions. Professor Brookes currently holds a Chair in Bioinformatics and Genomics at the University of Leicester in the UK, and an Adjunct Professorship in the Karolinska Institute in Sweden. He serves on the HUGO Council and is an elected member of the HUGO Human Genome Annotation Committee. He additionally acts as communicating Editor for Human Mutation. Other significant achievements include the highly acclaimed international Meeting series on "Single Nucleotide Polymorphism & Complex Genome Analysis", invention of the Dynamic Allele-Specific Hybridization genotyping technology, and creation of the Human Genome Variation database.Professor Brookes began his research career in the UK by studying Medicine and Medical Biochemistry (1st class qualification) at Manchester University, and then a molecular genetics PhD at the Imperial Cancer Research Fund and the University of London. He subsequently established a research group in the MRC Human Genetics Unit in Edinburgh, where amongst other things his team was involved in identifying the Presenilin-1 gene that causes Alzheimers Disease. He then moved to Sweden, first to Uppsala University where he received Docenture in Genetics, and then to the Karolinska Institute where he was awarded both Docenture and a Professorship in Genome Research.

Peter Butler (Netherlands) Peter Butler, Editorial Director, Biomedicine and Life Sciences, Springer Science+Business Media, The Netherlands. Further to an Honours Degree in Modern Languages and a period working for the British Council, Peter has been working in publishing for nearly 15 years. He joined the marketing department of Kluwer Academic Publishers in 1995, moving to the Editorial side in 1999. His team in The Netherlands currently manages the publication of approximately 45 journals.

Prof YT Chen (Taiwan) Professor Yuan-Tsong (Y-T) Chen and Mrs. Alice Der-Shan Chen were both originally from Taiwan and have been committed to biomedical research for over 30 years. They recognise the tremendous impact that genetics and genomics have had on the improvement of health and treatment of diseases and wish to establish the Chen Award to celebrate research accomplishments in Human Genetics and Genomics in Asia Pacific. Professor Chen received his MD degree from National Taiwan University (Taipei) and a PhD from Columbia University (USA). He is currently a Distinguished Research Fellow and Director of the Institute of Biomedical Sciences, Academia Sinica, Taiwan, and Professor of Pediatrics and Genetics at Duke University Medical Center (USA). Professor Chen is a physician/scientist, recognised for his work on human genetic disorders. His translational research leads to the development of now standard therapies for two devastating inherited metabolic diseases: a simple and effective cornstarch therapy for severe hypoglycemia in glycogen storage diseases and an enzyme replacement therapy, the first ever treatment, for a debilitating, progressive and often fatal myopathy called Pompe disease. Professor Chen has also identified the genetic basis of and developed DNA-based diagnosis for several major heritable diseases, and more recently, his team in Taiwan has uncovered genes/SNPs associated with drug-induced Stevens-Johnson syndrome and warfarin sensitivity. His latest pharmacogenomic studies of adverse drug reactions paved the way for personalised medicine by preventing drug toxicity with a gene test. Professor Chen is an elected member of Academia Sinica and of the Academy Sciences for the Developing World.

Dr. Liu Jian Jun (Singapore) Dr. Liu Jian Jun was educated at University of Science & Technology of China in Anhui, receiving a Bachelors of Science in Biology (1986) and a Masters of Science in Marine Biology from the Institute of Oceanology at the Chinese Academy of Sciences in Chandong China in 1989. He received his post-doctorate n Quantitative Genetics from Duke University in North Carolina, USA in 1997. Dr Liu spent 5 years as a research scientist in New York before he came to Singapore where he joined Genome Institute of Singapore as a group leader (human genetics) focusing on breast cancer, Parkinson’s disease and schizophrenia. He won the Young Investigator Award, National Alliance For Research on Schizophrenia and Depression in 2000 and another Young Investigator Award from Cure Autism Now Foundation in 2001.

Dr. Dhavendra Kumar (UK) Dr. Dhavendra Kumar is Consultant in Clinical Genetics at the University Hospital of Wales and Hon. Senior Research Fellow in the Institute of Medical Genetics, Cardiff University, Cardiff, Wales, United Kingdom. He is the lead Clinical Geneticist for Clinical Cardiovascular Genetics. After qualifying in Medicine from the King George’s Medical College, University of Lucknow, India, he completed postgraduate training in Pediatrics with an MD. Since 1980 he has pursued a career in Medical Genetics in the UK. In 1990 he became a Diplomate of the American Board of Medical Genetics. He is a Fellow of the American College of Medical Genetics (FACMG) and as well as Royal Colleges of Physicians (FRCP-London and FRCP-Ireland) and Paediatrics and Child Health (FRCPCH-UK). He has published three books (Genetic disorders of the Indian Subcontinent-Springer/Kluwer, Genomics and Clinical Medicine- Oxford University Press and Principles and Practice of Clinical Cardiovascular Genetics-Oxford University Press) and has several publications in pediatrics and clinical genetics. He established and developed a new biomedical journal (Genomic Medicine-Springer) that led to setting up the official journal of the Human Genome Organization (‘The HUGO Journal’). He serves on the editorial board of the HUGO Journal as Editor in Chief. He is currently a member of the publications committee of HUGO. Dr. Kumar’s current clinical and research interests include clinical cardiovascular genetics, applications of genomics in medicine and human health and promoting genetics and genomics for improving the health in emerging economies of the developing world. He is currently actively involved in promoting medical genetics and genomics in developing countries through education programs and establishing a comprehensive database on genomic variation and genetic disorders across several developing countries.

Prof Mark McCarthy (UK) Mark McCarthy is Robert Turner Professor of Diabetes at Oxford University, based at the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and at the Wellcome Trust Centre for Human Genetics. His work on the genetics and genomic basis of type 2 diabetes seeks to define the relationship between genetic variation, environment, intermediate phenotypes, and clinical disease, in the belief that such information will translate into a significant impact on clinical care for people with diabetes, through more rational and effective deployment of available preventative and therapeutic modalities. He obtained his medical degree at the University of Cambridge and postgraduate clinical training in general medicine, diabetes and endocrinology at the London Hospital. Following research training with – amongst others – Newton Morton and Eric Lander, he took up an appointment as Senior Lecturer (subsequently Professor in Genomic Medicine) at Imperial College in 1995, moving to Oxford as the Robert Turner Professor of Diabetes in 2002. In the past decade, his group has become established as one of the leading international teams working on the genetics of T2D, with expertise extending from physiological characterisation through to high-throughput genomic analysis and related issues in computational biology. Prof McCarthy currently leads the T2D component of the Wellcome Trust Case Control Consortium, and has been intimately involved in many of the recent discoveries generated by the application of genome wide association approaches to diabetes, obesity and related traits. His group is increasingly involved in efforts to understand how such information can be translated into advances in clinical management, and in extending these studies beyond the European context. He has a strong commitment to the wider research community, having served as a member and chair of the Diabetes UK Research Committee, and on Wellcome and MRC panels. He serves on the Editorial Board of Diabetes, Diabetologia, PLoS Medicine, Human Molecular Genetics and several other journals.

Prof. Sumio Sugano (Japan) Dr. Sumio Sugano is professor at Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo. He was the leader of FLJ cDNA collection project of Ministry of Economy and International Trade of Japan. Also, he heads the Scientific Research on Priority Areas "Medical Genome Science" of the Ministry of Education, Science, Sports and Culture of Japan. Dr. Sugano's research interests include gene structure and gene expressions, protein functions and application of genomics in disease studies.

The HUGO Journal

Official Journal of the Human Genome Organisation
Editors-in-Chief: A. Brookes; D Kumar; E. Liu; G.S. Ginsburg

• Anthony Brookes, University of Leicester, England, UK
• Dhavendra Kumar, University Hospital of Wales, Cardiff, UK
• Edison Liu, Genome Institute of Singapore, Singapore
• Geoffrey S. Ginsburg, Duke University, Durham NC , USA

HUGO Council Editors

• Samir Brahmachari, Institute of Genomics and Integrative Biology, CSIR, New Delhi, India
• Elspeth Bruford, European Bioinformatics Institute, Hinxton, England, UK
• David Cox, Pfizer, Cambridge MA, USA
• Anne Marie Frischauf, University of Salzburg, Salzburg, Austria
• Yoshihide Hayashizaki, RIKEN, Yokohama, Japan
• Veronica Van Heyningen, MRC, Edinburgh, Scotland, UK
• Gerardo Jimenez-Sanchez, National Institute of Genomic Medicine, Mexico
• Elsa Khusnutdinova, Russian Academy of Sciences, Ufa, Russia
• Doron Lancet, Weizmann Institute, Rehovot, Israel
• Li Jin, Fudan University, Shanghai, China
• Mark McCarthy, OCDEM, University of Oxford, England, UK
• Leena Peltonen-Palotie, University of Helsinki, Helsinki, Finland
• Hans Hilger Ropers, Max Planck Institute for Molecular Genetics, Berlin, Germany
• Stephen Scherer, The Hospital for Sick Children, Toronto, Canada
• Todd Taylor, RIKEN, Tokyo, Japan
• David Valle, Johns Hopkins University, Baltimore MD, USA

Editorial Board

• Russ Altman, Stanford University, Stanford CA, USA
• Wadie F. Bahou, Stony Brook University, NY, USA
• Alan Bittles, Edith Cowan University, Perth WA, Australia
• Jenefer Blackwell, Telethon Institute for Child Health Research, Perth WA, Australia
• Ruth Chadwick, Cardiff University, Wales, UK
• Angus Clarke, Cardiff University, Wales, UK
• Abdallah Daar, University of Toronto, Toronto, Canada
• George Davey-Smith, University of Bristol, Bristol, England, UK
• Ian Frayling, University Hospital of Wales, UK
• Muin Khoury, Centers for Disease Control and Prevention, Atlanta GA, USA
• Samantha Knight, University of Oxford, UK
• Stephen Lam, Department of Health, Hong Kong SAR, China
• Grant Montgomery, Queensland Institute of Medical Research, Brisbane, Australia
• David W. Mount, University of Arizona, Tucson AZ, USA
• Michael Owen, Cardiff University, Wales, UK
• Michael Parker, ETHOX, University of Oxford, England, UK
• Stephen Pennington, University College Dublin, Ireland
• Raj Ramesar, University of Cape Town, South Africa
• Anthony Reeve, niversity of Otago, New Zealand
• Julian Sampson, Cardiff University, Wales, UK
• Mark Seielstad, Genome Institute of Singapore, Singapore
• Maren Scheuner, RAND Corporation, Santa Monica, CA, USA
• Raj Thakker, OCDEM, University of Oxford, UK
• Ishwar C. Verma, Sir Ganga Ram Hospital, New Delhi, India
• Wei Wang, Capital Medical University, Beijing, China
• Yoshiji Yamada, Mie University,Mie, Japan
• Ron Zimmern, University of Cambridge, England, UK

Advisory Editors

• Walter Bodmer, Oxford, UK
• David N. Cooper, Cardiff, UK
• Gordon Duff, Sheffield, UK
• Peter Harper, Cardiff, UK
• David Weatherall, Oxford, UK

Press Release

• Springer to collaborate with the Human Genome Organisation